Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care
- PMID: 33736822
- DOI: 10.1016/j.jacc.2021.02.006
Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care
Keywords: heart failure; medical therapy; sodium glucose cotransporter-2 inhibitors.
Conflict of interest statement
Funding Support and Author Disclosures Dr. Greene has received research support from the American Heart Association, Amgen, AstraZeneca, Bristol Myers Squibb, Merck, and Novartis; has served on advisory boards for Amgen and Cytokinetics; and serves as a consultant for Amgen and Merck. Dr. Khan has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.J Am Coll Cardiol. 2021 Mar 23;77(11):1397-1407. doi: 10.1016/j.jacc.2021.01.044. J Am Coll Cardiol. 2021. PMID: 33736821 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical